-
1
-
2دورية أكاديمية
المؤلفون: Ogun GO; Department of Pathology, University of Ibadan/University College Hospital, Ibadan, Nigeria., Ezenkwa US; Department of Pathology, University of Ibadan/University College Hospital, Ibadan, Nigeria., Babatunde TO; Department of Pathology, University of Ibadan/University College Hospital, Ibadan, Nigeria., Obiagwu AE; Department of Community Medicine, Edo University Iyamho, Iyamho, Nigeria., Nweke MC; Department of Pathology, University of Ibadan/University College Hospital, Ibadan, Nigeria., Adegoke OO; Department of Pathology, University of Ibadan/University College Hospital, Ibadan, Nigeria., Olulana OO; Department of Surgery/Paediatric Surgery, University of Ibadan/University College Hospital, Ibadan, Nigeria., Brown BJ; Department of Paediatrics (Haematology & Oncology Unit), University of Ibadan/University College Hospital, Ibadan, Nigeria.
المصدر: International journal of clinical practice [Int J Clin Pract] 2021 Apr; Vol. 75 (4), pp. e13951. Date of Electronic Publication: 2021 Jan 09.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Hindawi Country of Publication: India NLM ID: 9712381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-1241 (Electronic) Linking ISSN: 13685031 NLM ISO Abbreviation: Int J Clin Pract Subsets: MEDLINE
مواضيع طبية MeSH: Rhabdomyosarcoma*/therapy , Sarcoma*, Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Nigeria ; Prognosis ; Retrospective Studies